DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced that its President and CEO, Dr. Oren Gilad, will present at the Lytham Partners Fall 2024 Investor Conference on October 1.
The presentation, scheduled for 12:30 PM ET, will be webcasted, offering insights into the company’s current initiatives.
Additionally, Aprea’s management will engage in virtual one-on-one meetings with investors throughout the event, facilitating direct communication and discussions about potential opportunities.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.